Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
1354631-33-6
|
| gptkbp:class |
recreational drug
cathinone derivative |
| gptkbp:effect |
stimulant
psychoactive |
| gptkbp:hasMolecularFormula |
C16H21NO3
|
| gptkbp:hasSMILES |
CCCC(N1CCCC1)C2=CC3=C(C=C2)OCO3
|
| https://www.w3.org/2000/01/rdf-schema#label |
DB-020
|
| gptkbp:IUPACName |
1-(2,3-benzodioxol-5-yl)-2-pyrrolidin-1-ylpentan-1-one
|
| gptkbp:legalStatus |
illegal in some countries
|
| gptkbp:molecularWeight |
275.34 g/mol
|
| gptkbp:PubChem_CID |
57427760
|
| gptkbp:relatedTo |
MDPV
|
| gptkbp:routeOfAdministration |
injection
oral insufflation |
| gptkbp:subjectOf |
forensic toxicology studies
|
| gptkbp:bfsParent |
gptkb:Decibel_Therapeutics
|
| gptkbp:bfsLayer |
7
|